661 related articles for article (PubMed ID: 22766086)
21. Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis.
Vieira MC; Zwillich SH; Jansen JP; Smiechowski B; Spurden D; Wallenstein GV
Clin Ther; 2016 Dec; 38(12):2628-2641.e5. PubMed ID: 27889300
[TBL] [Abstract][Full Text] [Related]
22. Advances in the medical management of rheumatoid arthritis.
Scott DL
Hosp Med; 2002 May; 63(5):294-7. PubMed ID: 12066349
[TBL] [Abstract][Full Text] [Related]
23. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.
Malottki K; Barton P; Tsourapas A; Uthman AO; Liu Z; Routh K; Connock M; Jobanputra P; Moore D; Fry-Smith A; Chen YF
Health Technol Assess; 2011 Mar; 15(14):1-278. PubMed ID: 21439251
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Bae SC
Int J Rheum Dis; 2016 Nov; 19(11):1103-1111. PubMed ID: 26692536
[TBL] [Abstract][Full Text] [Related]
25. The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrollment: data from a systematic review and meta-analysis.
Favalli EG; Pregnolato F; Biggioggero M; Meroni PL
Semin Arthritis Rheum; 2014 Jun; 43(6):730-7. PubMed ID: 24332807
[TBL] [Abstract][Full Text] [Related]
26. [Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
Suzuki Y; Wakabayashi T; Saito E; Suwa A
Clin Calcium; 2007 Apr; 17(4):546-52. PubMed ID: 17404484
[TBL] [Abstract][Full Text] [Related]
27. Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis.
Yu X; Wang L; Xu P; Lu W; Lan G; Ping L; Wang X; Tian J; Liu J
J Rheumatol; 2012 Jun; 39(6):1171-8. PubMed ID: 22505700
[TBL] [Abstract][Full Text] [Related]
28. [Recent topics on new biological agents for treatment of rheumatoid arthritis].
Saito K; Tanaka Y
Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2418-23. PubMed ID: 19149039
[No Abstract] [Full Text] [Related]
29. [Rational therapeutic approach in rheumatoid arthritis].
Tłustochowicz W
Ann Acad Med Stetin; 2006; 52 Suppl 2():5-10. PubMed ID: 17471832
[TBL] [Abstract][Full Text] [Related]
30. Sequential use of biologic therapy in rheumatoid arthritis.
Buch MH
Curr Opin Rheumatol; 2010 May; 22(3):321-9. PubMed ID: 20190641
[TBL] [Abstract][Full Text] [Related]
31. New therapies for treatment of rheumatoid arthritis.
Smolen JS; Aletaha D; Koeller M; Weisman MH; Emery P
Lancet; 2007 Dec; 370(9602):1861-74. PubMed ID: 17570481
[TBL] [Abstract][Full Text] [Related]
32. Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.
Favalli EG; Biggioggero M; Marchesoni A; Meroni PL
Rheumatology (Oxford); 2014 Sep; 53(9):1664-8. PubMed ID: 24729445
[TBL] [Abstract][Full Text] [Related]
33. Newer biological agents in the treatment of rheumatoid arthritis: do the benefits outweigh the risks?
Nurmohamed MT
Drugs; 2009 Oct; 69(15):2035-43. PubMed ID: 19791825
[TBL] [Abstract][Full Text] [Related]
34. [Effectiveness of biological treatments based on ACR70 response in rheumatoid arthritis: indirect comparison and meta-regression using Bayes-model].
Brodszky V
Orv Hetil; 2011 Jun; 152(23):919-28. PubMed ID: 21592952
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
Singer O; Gibofsky A
Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
[TBL] [Abstract][Full Text] [Related]
36. [Proposal for biologic drugs therapy in rheumatoid arthritis].
Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S; Kaliterna DM; Hanih M; Novak S
Reumatizam; 2010; 57(1):29-35. PubMed ID: 20941938
[TBL] [Abstract][Full Text] [Related]
37. [Rheumatoid arthritis: strategies for biotherapy].
Nau JY
Rev Med Suisse; 2012 Oct; 8(358):1988-9. PubMed ID: 23198655
[No Abstract] [Full Text] [Related]
38. Management of RA medications in pregnant patients.
Østensen M; Förger F
Nat Rev Rheumatol; 2009 Jul; 5(7):382-90. PubMed ID: 19506586
[TBL] [Abstract][Full Text] [Related]
39. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
Behrens F; Koehm M; Burkhardt H
Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
[TBL] [Abstract][Full Text] [Related]
40. Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis.
Henes JC; Schedel J; Kanz L; Koetter I
Rheumatol Int; 2010 Mar; 30(5):709-12. PubMed ID: 20012622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
